Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jiapei Guo"'
Autor:
Weixi Chen, Zekun Bai, Wen Bai, Wei Wang, Jiapei Guo, Mengnan Guo, Yingying Sai, Jun Shi, Jinghua Wu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Hepatocellular carcinoma (HCC) is a symptomatic disease involed multi-stage program. Here, we elucidated the molecular mechanism of LncTUG1 in the regulation of HCC evolvement. And that may in all likelyhood supply a innovative latent target
Externí odkaz:
https://doaj.org/article/125dd1ae4be340e98eb2fa2fb709dfe1
Autor:
Zhuolin Wang, Yang Zhang, Rirong Yang, Yujia Wang, Jiapei Guo, Ruya Sun, Yuan Zhou, Li Su, Qing Ge, Yingmei Feng
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Resulting from severe inflammation and cell destruction, COVID-19 patients could develop pulmonary fibrosis (PF), which remains in the convalescent stage. Nevertheless, how immune response participates in the pathogenesis of PF progression is not wel
Externí odkaz:
https://doaj.org/article/1cea2f7d3dc447468c6bcd99f7f509d4
Autor:
Mengnan Guo, Ning Li, Jianxia Zheng, Wei Wang, Yan Wu, Xu Han, Jiapei Guo, Weixi Chen, Zekun Bai, Wen Bai, Jinghua Wu
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is an aggressive tumor with a high mortality rate because of the limited systemic and locoregional treatment modalities. The development and progression of HCC depend on ep
Externí odkaz:
https://doaj.org/article/96753efe45cf493797c7c51a76161e26
Publikováno v:
Sustainability; Volume 15; Issue 9; Pages: 7217
China’s pursuit of sustainable and healthy economic growth requires the promotion of high-quality development. While many scholars have studied high-quality development, few have examined the coupling and coordination among its internal systems. Th
Autor:
Weixi Chen, Zekun Bai, Wen Bai, Wei Wang, Jiapei Guo, Mengnan Guo, Yingying Sai, Jun Shi, Jinghua Wu
Background: Hepatocellular carcinoma (HCC) is a symptomatic disease involed multi-stage program. Here, we elucidated the molecular mechanism of LncTUG1 in the regulation of HCC evolvement. And that may in all likelyhood supply a innovative latent tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c9474982e5b80c801237144e07515d
https://doi.org/10.21203/rs.3.rs-2111715/v2
https://doi.org/10.21203/rs.3.rs-2111715/v2
Autor:
Yang Liu, Jiapei Guo, Yuting Yi, Xuan Gao, Lei Wen, Wenbing Duan, Zhaohong Wen, Yaoyao Liu, Yanfang Guan, Xuefeng Xia, Ling Ma, Rong Fu, Lihong Liu, Xiaojun Huang, Qing Ge, Jin Lu
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4914
Multiple myeloma (MM) is highly heterogenous and dynamic in its genomic abnormalities. Capturing a representative image of these alterations is essential in understanding the molecular pathogenesis and progression of the disease but was limited by si
Autor:
Zekun Bai, Jinghua Wu, Weixi Chen, Wen Bai, Li Ning, Jiapei Guo, Mengnan Guo, Yan Wu, Jianxia Zheng, Han Xu, Wang Wei
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology & Hepatology
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is an aggressive tumor with a high mortality rate because of the limited systemic and locoregional treatment modalities. The development and progression of HCC depend on ep
Autor:
Jiapei Guo, Leilei Li, Bin Guo, Dianxing Liu, Jun Shi, Chuntao Wu, Junmao Chen, Xiaowei Zhang, Jinghua Wu
Publikováno v:
Translational Cancer Research. 7:765-781